Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

February 25, 2024

Study Completion Date

March 22, 2024

Conditions

Gastric CancerBone Marrow MetastasisDisseminated Intravascular Coagulation

Interventions

DRUG

5-fluorouracil

200mg/square metre/day civ D1-D21

DRUG

Docetaxel

25mg/square metre ivdrip D1, D8, D15

Trial Locations (1)

Jian Xiao, Guangzhou

All Listed Sponsors

lead

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

NCT04547153 - Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC | Biotech Hunter | Biotech Hunter